EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access · CC BY-NC-ND 4.0

A brief history of Aβ imaging

Ann D Cohen, Victor L Villemagne

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70291 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Ann D Cohen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, The University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Brain, Neuroimaging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIDA NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β‐Amyloid (Αβ) imaging revolutionized the in vivo assessment of Alzheimer's disease (AD) Αβ pathology and its changes over time, increasing our insights into Aβ deposition in the brain by providing highly accurate, reliable, and reproducible quantitative statements of regional and global Aβ burden in the brain, proving essential for the differential diagnosis, staging, and evaluation of disease‐specific anti‐Αβ therapeutic approaches. Longitudinal observations, coupled with different disease‐specific biomarkers to assess potential downstream effects of Aβ, have confirmed that Αβ deposition in the brain starts decades before the onset of symptoms. Aβ imaging studies continue to refine our understanding of the role of Αβ deposition in AD, and its relation to other imaging and fluid biomarkers. Highlights Αβ imaging revolutionized the in vivo assessment of Alzheimer's disease Αβ pathology. Αβ imaging has increased our insights into Aβ deposition in the brain by providing highly accurate, reliable, and reproducible quantitative statements of regional and global Αβ burden in the brain. Αβ imaging is essential for the differential diagnosis, staging, and evaluation of disease‐specific anti‐Αβ therapeutic approaches. Αβ imaging studies continue to refine our understanding of the role of Αβ deposition in Alzheimer's disease, and its relation to other imaging and fluid biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesBrainNeuroimagingHumansHistory, 21st CenturyHistory, 20th CenturyBiomarkersPositron-Emission Tomography

Stichwörter der Autor:innen

Alzheimer's diseaseamyloidamyloid tracersaβ imagingcentiloids

Substanzen

Amyloid beta-PeptidesBiomarkers

Autor:innen und Institutionen

  • Department of Psychiatry, The University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Förderung

  • NIH HHS
  • NIDA NIH HHS
  • NIA NIH HHS
  • Aging Mind Foundation
  • National Institute of Aging
  • Intramural Research Program, National Institute on Drug Abuse
  • National Institutes of Health
  • National Institute on Drug Abuse

Zitieren

APA

Cohen, A. D., & Villemagne, V. L. (2025). A brief history of Aβ imaging. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70291

Vancouver

Cohen AD, Villemagne VL. A brief history of Aβ imaging. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70291

BibTeX
@article{Cohen2025,
  author = {Cohen, Ann D and Villemagne, Victor L},
  title = {A brief history of Aβ imaging},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70291}
}
Kostenlos starten →